Very late antigen-1 mediates corneal lymphangiogenesis

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 7, 2011, Pages 4808-4812

  Grimaldo, Sammy ^a   Yuen, Don ^a   Ecoiffier, Tatiana ^a   Chen, Lu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERY LATE ACTIVATION ANTIGEN 1; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLAMMATION; LYMPHANGIOGENESIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; CORNEA NEOVASCULARIZATION; DISEASE MODEL; FLUORESCENCE MICROSCOPY; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, LYMPHATIC; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN ALPHA1BETA1; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; RNA;

EID: 79960056446     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6580     Document Type: Article

References (38)

1. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010;140:460-476.
2. Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci. 2008;1131:225-234.
3. Chen L. Ocular lymphatics: state-of-the-art review. Lymphology. 2009;42:66-76.
4. Brown P. Lymphatic system: unlocking the drains. Nature. 2005;436:456-458.
5. Kerjaschki D. Lymphatic neoangiogenesis in renal transplants: a driving force of chronic rejection? J Nephrol. 2006;19:403-406.
6. Folkman J, Kaipainen A. Genes tell lymphatics to sprout or not. Nat Immunol. 2004;5:11-12.
7. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 2002;16:773-783.
8. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144:789-801.
9. Radhakrishnan K, Rockson SG. The clinical spectrum of lymphatic disease. Ann N Y Acad Sci. 2008;1131:155-184.
10. Cueni LN, Detmar M. The lymphatic system in health and disease. Lymphat Res Biol. 2008;6:109-122.
11. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946-953.
12. Witte MH, Bernas MJ, Martin CP, Witte CL. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc Res Tech. 2001;55:122-145.
13. Wuest TR, Carr DJ. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med. 2009;207:101-115.
14. Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003;22:273-281.
15. Chong EM, Dana MR. Graft failure, IV: immunologic mechanisms of corneal transplant rejection. Int Ophthalmol. 2008;28:209-222.
16. Dietrich T, Bock F, Yuen D, et al. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol. 2010;184:535-539.
17. Berman AE, Kozlova NI, Morozevich GE. Integrins: structure and signaling. Biochemistry (Mosc). 2003;68:1284-1299.
18. Stepp MA. Corneal integrins and their functions. Exp Eye Res. 2006;83:3-15.
19. Ben-Horin S, Bank I. The role of very late antigen-1 in immunemediated inflammation. Clin Immunol. 2004;113:119-129.
20. Andreasen SO, Thomsen AR, Koteliansky VE, et al. Expression and functional importance of collagen-binding integrins, alpha 1 beta 1 and alpha 2 beta 1, on virus-activated T cells. J Immunol. 2003;171:2804-2811.
21. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990;8:365-400.
22. Chen L, Huq S, Gardner H, de Fougerolles AR, Barabino S, Dana MR. Very late antigen 1 blockade markedly promotes survival of corneal allografts. Arch Ophthalmol. 2007;125:783-788.
23. Chen L, Cursiefen C, Barabino S, Zhang Q, Dana MR. Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol Vis Sci. 2005;46:4536-4540.
24. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med. 2004;10:813-815.
25. Zhang H, Hu X, Tse J, Tilahun F, Qiu M, Chen L. Spontaneous lymphatic vessel formation and regression in the murine cornea. Invest Ophthalmol Vis Sci. 2010;52:334-338.
26. Yuen D, Pytowski B, Chen L. Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages. Invest Ophthalmol Vis Sci. 2011;52:2593-2597.
27. Ecoiffier T, Yuen D, Chen L. Differential distribution of blood and lymphatic vessels in the murine cornea. Invest Ophthalmol Vis Sci. 2010;51:2436-2440.
28. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113:1040-1050.
29. Chung ES, Chauhan SK, Jin Y, et al. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol. 2009;175:1984-1992.
30. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008;126:219-225.
31. Hamrah P, Liu Y, Zhang Q, Dana MR. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci. 2003;44:581-589.
32. Ji RC. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol. 2006;4:83-100.
33. Pozzi A, Wary KK, Giancotti FG, Gardner HA. Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo. J Cell Biol. 1998;142:587-594.
34. Dietrich T, Onderka J, Bock F, et al. Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol. 2007;171:361-372.
35. Wuest TR, Carr DJ. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med. 2009;207:101-115, S101-S102.
36. Ling S, Lin H, Liang L, et al. Development of new lymphatic vessels in alkali-burned corneas. Acta Ophthalmol. 2009;87:315-322.
37. Kerjaschki D, Huttary N, Raab I, et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med. 2006;12:230-234.
38. Geissler HJ, Dashkevich A, Fischer UM, et al. First year changes of myocardial lymphatic endothelial markers in heart transplant recipients. Eur J Cardiothorac Surg. 2006;29:767-771.